RiboCure Pharmaceuticals AB
Clinical trials sponsored by RiboCure Pharmaceuticals AB, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for rare liver infection: RBD1016 trial underway Results expected Sep 2026 (estimated)
- New drug aims to tame dangerous blood fats in heart patients Results expected May 2027 (estimated)